이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

경대퇴 절단 환자의 오수르 파워 슬관절(Ossur Power Knee)에 대한 생체역학적 평가 (OPKTFA)

2026년 9월 17일 업데이트: VA Office of Research and Development

전동식 무릎 굴곡 및 확장 기능을 갖춘 경대퇴 보철물이 이동성을 향상합니까? Ossur Power Knee의 생체역학적 평가

Microprocessor-controlled knees (MPKs) do not typically utilize motors to power joint rotation, but they automatically adjust resistance or damping in the joint to improve swing- and/or stance-phase control as appropriate for the prosthesis user during gait. The Ossur Power Knee is the only commercially-available MPK that uses a motor to provide active power generation during walking and other activities. The purpose of this proposed investigation is to perform and compare biomechanical evaluations of the Power Knee and Ossur Rheo XC, a passive MPK, during walking and other activities by prosthesis users. Furthermore, mobility between male and female subjects will be compared to determine if there are differences in prosthetic knee usage on the basis of sex.

연구 개요

상세 설명

The anatomical knee is a complex, polycentric joint characterized by a large range of motion in the sagittal plane and limited mobility in the coronal and transverse planes. The sagittal plane motion is used for progression in stance phase, and limb clearance and advancement in swing. Limb prostheses are intended to restore function and cosmesis in persons with limb loss. The complexity and function of prosthetic components have advanced significantly as technology has improved, but a state-of-the-art artificial limb is still a relatively poor substitute for an anatomical one. Microprocessor-controlled knees (MPKs) do not typically utilize motors to power joint rotation, but they automatically adjust resistance or damping in the joint to improve swing- and/or stance-phase control as appropriate for the user during gait. The Ossur Power Knee, which was first introduced in 2006, is the only MPK that uses a motor to provide active power generation during walking and other activities involving knee flexion and extension. Last year, Ossur released the 3rd generation of its Power Knee and appears to have addressed many of the previous shortcomings in terms of reduced weight, less noise, lower cost and longer battery life. Therefore, the newest version of the Power Knee warrants a fresh evaluation since it is, in essence, substantially different in design and function from previous models.

The purpose of this proposed investigation is to perform biomechanical evaluations of the new Ossur Power Knee during walking and other activities by transfemoral prosthesis users. Using a cross-over experimental design, approximately 20 unilateral, transfemoral amputee subjects (10 men and 10 women) will be evaluated in the Jesse Brown VAMC Motion Analysis Research Laboratory (MARL) while wearing the Ossur Power Knee and Ossur Rheo XC, which is a passive MPK device. Furthermore, the Ossur Power Knee may offer distinct advantages to female prosthesis users, so mobility will be compared between men and women to determine if differences exist on the basis of sex. The specific aims and hypotheses of this project are:

Aim 1: To compare the effects of the Ossur Power Knee and Ossur Rheo XC on the gait of unilateral, transfemoral prosthesis users during level walking. Kinematic and kinetic data will be collected as subjects walk in the MARL. Hypothesis--the active knee flexion and extension provided by the Ossur Power Knee will (1) improve walking performance, and (2) reduce metabolic energy cost during ambulation.

Aim 2: To compare the effects of the Ossur Power Knee and Ossur Rheo XC on stairs, slopes and during sit-to-stand/stand-to-sit activities of unilateral, transfemoral prosthesis users. Kinematic data will be collected as subjects perform these activities. Hypothesis--subjects will have improved performance when using the Ossur Power Knee.

Aim 3: To analyze and compare gender specific data between subjects using the Ossur Power Knee and the Ossur Rheo XC. Hypothesis--male and female subjects will demonstrate substantially different abilities to use the two knee components, indicating that gender specific components should be further investigated and developed. Research focusing on the unique prosthetic needs of women Veterans is currently a special emphasis area of the VA RR&D Service.

Subjects will also be administered questionnaires and provided at-home diaries to document their perceptions of comfort, exertion and stability while using the different prosthetic knee units.

The repeated-measures, cross-over protocol design enables each subject to serve as their own control, and it will be determined whether statistically significant changes occur in their performance measures. A two-way mixed-methods ANOVA will be used to assess the main and interaction effects of sex (male, female) and knee type (Ossur Power Knee, Rheo XC). As a conservative approach, a Bonferroni correction will be used to account for the family-wise Type I error rate because multiple outcomes will be used to address each hypothesis.

Increased understanding about how the Ossur Power Knee affects the abilities of transfemoral prosthesis users will facilitate appropriate component selection by prosthetists and ultimately improve quality of life for prosthesis users.

연구 유형

중재적

등록 (추정된)

20

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 연락처 백업

연구 장소

    • Illinois
      • Chicago, Illinois, 미국, 60612
        • 모병
        • Jesse Brown VA Medical Center, Chicago, IL
        • 연락하다:
        • 수석 연구원:
          • Steven A Gard, PhD
        • 연락하다:

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

45년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Unilateral, transfemoral amputation (any etiology)
  • Residual limb length classified as standard (i.e., medium) to long
  • Prosthesis user for at least 1 year prior to enrolling in the study
  • K3 or K4 level ambulator
  • Good sensation on their residual limb(s) (upon routine clinical examination)
  • Good skin integrity upon visual inspection
  • Does not require the use of assistive devices to walk for short distances
  • Not currently taking medications that are known to affect balance or gait
  • Presents with good socket fit based upon a standard assessment by the study prosthetist

Exclusion Criteria:

  • Bilateral amputations
  • Individuals with a knee disarticulation

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 크로스오버 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Ossur Power Knee

Subjects will be fitted with the Ossur Power Knee, which has powered flexion and extension.

Subjects will be fitted and trained on the Ossur Power Knee. An accommodation of 1 month will be provided prior to evaluation with the knee joint.

다른 이름들:
  • 오수르 파워 니
활성 비교기: Ossur Rheo XC Knee

Subjects will be fitted with the Ossur Rheo XC Knee, which is a conventional microprocessor-controlled prosthetic knee joint that modulates the amount of damping during flexion and extension.

Subjects will be fitted and trained on the Ossur Rheo XC Knee. An accommodation of 1 month will be provided prior to evaluation with the knee joint.

다른 이름들:
  • Ossur Rheo

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Walking speed
기간: To be measured after the 1-month accommodation period of wearing each prosthetic knee component

Walking speed will be measured as participants walk on level ground at slow, normal and fast speeds.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component
Metabolic energy cost
기간: To be measured after the 1-month accommodation period of wearing each prosthetic knee component

The metabolic energy rate will be measured as subjects walk at their freely selected speed on a level treadmill, which will be converted to metabolic energy cost (energy expended per unit distance).

To be measured after the 1-month accommodation period of wearing each prosthetic knee component
Sit-to-stand/stand-to-sit symmetry
기간: To be measured after the 1-month accommodation period of wearing each prosthetic knee component

Knee kinematics and load distribution between the sound and prosthetic sides will be measured as participants stand up and sit down in a chair.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component

2차 결과 측정

결과 측정
측정값 설명
기간
Step length
기간: To be measured after the 1-month accommodation period of wearing each prosthetic knee component

The step lengths of the sound and prosthetic sides will be measured as participants walk on level ground at slow, normal and fast speeds.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component
Toe clearance during swing phase
기간: To be measured after the 1-month accommodation period of wearing each prosthetic knee component

Toe clearance during swing phase on the prosthetic side will be measured as participants walk on level ground at slow, normal and fast speeds.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component
Sound leg loading rate
기간: To be measured after the 1-month accommodation period of wearing each prosthetic knee component

The sound leg loading rate during walking will be measured as participants walk on level ground at slow, normal and fast speeds.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component
Kinematics of pelvic motion
기간: To be measured after the 1-month accommodation period of wearing each prosthetic knee component

Pelvic tilt, rotation and obliquity will be measured as participants walk on level ground at slow, normal and fast speeds.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Steven A Gard, PhD, Jesse Brown VA Medical Center, Chicago, IL

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2024년 4월 1일

기본 완료 (추정된)

2027년 1월 31일

연구 완료 (추정된)

2027년 3월 31일

연구 등록 날짜

최초 제출

2024년 1월 11일

QC 기준을 충족하는 최초 제출

2024년 1월 11일

처음 게시됨 (실제)

2024년 1월 23일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 22일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 17일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • A4541-R
  • RX004541-01A2 (기타 보조금/기금 번호: VA RRD)
  • 5I01RX004541-02 (미국 NIH 보조금/계약)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

IPD 계획 설명

A Limited Dataset (LDS) will be created and shared pursuant to a Data Use Agreement (DUA) appropriately limiting use of the dataset and prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset. Results from this study will be freely disseminated via presentations at professional conferences and publications in scientific journals. Additionally, data acquired for this project will be shared with those investigators who make a formal request to the PI and can demonstrate a legitimate and justifiable cause for utilization of such data. All requests for these data will be discussed with the VA scientific program manager.

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

미국에서 제조되어 미국에서 수출되는 제품

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다